2016
DOI: 10.1590/2359-3997000000210 View full text |Buy / Rent full text
|
|

Abstract: Objective: To describe the safety and efficacy of pegvisomant therapy and the predictors of treatment response in acromegaly patients at a single tertiary reference center in Brazil. Materials and methods: We retrospectively reviewed the clinical, hormonal and radiological data of acromegaly patients treated with pegvisomant in our center. We also evaluated the presence of the d3 isoform of the growth hormone receptor (d3GHR). Results: Twenty-seven patients were included (17 women). Pegvisomant was used in com… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
3
7
2

Publication Types

Select...

Relationship

0
0

Authors

Journals